Health & Medicine Tysabri safety and pml risk stratification april 2013

1. Natalizumab Safety Update &PML Risk StratificationApril 2013Gavin GiovannoniBarts and The London 2. Benefit / RiskBenefitRiskNatalizumab81% reduction inrelapse rate164%…

Health & Medicine Natalizumab Safety Update January 2013

1. TYSABRI Safety Update & PML Risk Stratification Barts HealthJanuary 2013 Gavin Giovannoni TY-PAN-0587 Date of preparation: January 2013 2. Benefit / Risk 81% reduction…

Business Tysabri safety and pml risk stratification ty pan-0463q august

1. TYSABRI Safety Update & PML Risk StratificationBarts Health NHS Trust25th AugustProfessor Gavin GiovannoniTY-PAN-0463q Date of preparation: July 2012 2. Benefit…